In last trading session, Assembly Biosciences Inc (NASDAQ:ASMB) saw 0.37 million shares changing hands with its beta currently measuring 0.53. Company’s recent per share price level of $0.72 trading at $0.02 or 2.86% at ring of the bell on the day assigns it a market valuation of $47.31M. That closing price of ASMB’s stock is at a discount of -147.22% from its 52-week high price of $1.78 and is indicating a premium of 11.11% from its 52-week low price of $0.64. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 1.03 million shares which gives us an average trading volume of 1.80 million if we extend that period to 3-months.
For Assembly Biosciences Inc (ASMB), analysts’ consensus is at an average recommendation of an Overweight while assigning it a mean rating of 2.00. Splitting up the data highlights that, out of 2 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 1 suggested the stock as a Hold whereas 1 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -$0.24 in the current quarter.
Assembly Biosciences Inc (NASDAQ:ASMB) trade information
Upright in the green during last session for gaining 2.86%, in the last five days ASMB remained trading in the red while hitting it’s week-highest on Wednesday, 11/15/23 when the stock touched $0.72 price level, adding 6.49% to its value on the day. Assembly Biosciences Inc’s shares saw a change of -44.62% in year-to-date performance and have moved -3.36% in past 5-day. Assembly Biosciences Inc (NASDAQ:ASMB) showed a performance of -31.43% in past 30-days. Number of shares sold short was 0.79 million shares which calculate 0.17 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of $3.00 to the stock, which implies a rise of 76.0% to its current value. Analysts have been projecting $3.00 as a low price target for the stock while placing it at a high target of $3.00. It follows that stock’s current price would drop -316.67% in reaching the projected high whereas dropping to the targeted low would mean a loss of -316.67% for stock’s current value.
Assembly Biosciences Inc (ASMB) estimates and forecasts
Statistics highlight that Assembly Biosciences Inc is scoring comparatively higher than the scores of other players of the relevant industry. The company lost -30.77% of value to its shares in past 6 months, showing an annual growth rate of 38.02% while that of industry is 14.80. Apart from that, the company came raising its revenue forecast for fiscal year 2023. The company is estimating its revenue growth to increase by 47.80% in the current quarter and calculating 27.00% increase in the next quarter.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 4.41% during past 5 years. In 2023, company’s earnings growth rate is likely to be around 38.28% while estimates for its earnings growth in next 5 years are of 17.00%.
Assembly Biosciences Inc is more likely to be releasing its next quarterly report on November 08 and investors are confident in the company announcing better current-quarter dividends despite the fact that it has been facing issues arising out of mounting debt.
Assembly Biosciences Inc (NASDAQ:ASMB)’s Major holders
Insiders are in possession of 1.59% of company’s total shares while institution are holding 23.26 percent of that, with stock having share float percentage of 23.64%. Investors also watch the number of corporate investors in a company very closely, which is 23.26% institutions for Assembly Biosciences Inc that are currently holding shares of the company. Vanguard Group Inc is the top institutional holder at ASMB for having 2.24 million shares of worth $1.61 million. And as of Sep 29, 2023, it was holding 3.41% of the company’s outstanding shares.
The second largest institutional holder is Alerce Investment Management, L.P., which was holding about 2.23 million shares on Sep 29, 2023. The number of shares represents firm’s hold over 3.39% of outstanding shares, having a total worth of $1.6 million.
On the other hand, Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund are the top two Mutual Funds which own company’s shares. As of Jun 29, 2023, the former fund manager was holding 1.38 million shares of worth $0.99 million or 2.10% of the total outstanding shares. The later fund manager was in possession of 0.52 million shares on Jun 29, 2023, making its stake of worth around $0.37 million in the company or a holder of 0.79% of company’s stock.